Industry Intelligence Report
OTC Pharma Report 2026
Actionable intelligence on how OTC brands win closer to the chemist counter — availability, shelf, schemes and distributor execution across India.
Where OTC demand is won or lost
The shifts reshaping chemist-counter execution
What's next for distribution-led growth
What you'll discover inside
01
Demand flow
Where OTC demand is won or lost
02
Brand playbooks
What leading OTC brands changed first
03
Structural shifts
The five forces most brands will miss
04
Future outlook
What 2026 → 2030 looks like
Why this report matters
India's OTC pharma market is growing fast, driven by self-care, rising chemist coverage and an increasingly complex multi-stockist route to market.
The brands pulling ahead all share one advantage: they can see the chemist counter clearly — orders, stock, shelves, schemes and field execution.
This report turns that complexity into clear, route-to-market decisions you can act on with confidence.
Evidence-based insights from real market signals
Covers chemist counter, stockists, shelf & schemes
Spot execution gaps and leakage early
Built for leaders who drive distribution growth
Who should read this
Chief Sales Officer / VP of Sales
Chief Information Officer (CIO)
Chief Technology Officer (CTO)
Head of Distribution & Channel Sales
Head of Trade Marketing
Head of IT / Digital Transformation
National & Regional Sales Managers
Sales Operations & RTM Leaders
Make smarter route-to-market decisions with real market intelligence.
Download the OTC Pharma Report 2026.